Linking Neuroscience and Behavior in COVID-19 examines the impact of the virus and pandemic on behavior and mental health. Chapters look at those with pre-existing conditions, including dementia and multiple sclerosis, and how the pandemic has burdened them further. There is also discussion on the mental health consequences the pandemic has had and continues to have on the broad populace, including depression and anxiety, as well as neurological effects of the virus itself. Finally, managing care and treatment of conditions - those preceding, caused by, or emerging for the first time during the pandemic are also detailed.
1. Linking Neuroscience and Behavior in COVID-19 - p. iv 2. Cover - p. iv 3. Title Page - p. iv 4. Copyright Page - p. iv 5. Tables of Contents - p. iv 6. Dedication - p. iv 7. Contributors - p. xxi 8. Preface - p. xxvii 9. Chapter 1 The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic - p. 3 10. Chapter 2 Different variants of SARS-CoV-2 - p. 13 11. Chapter 3 Lateral flow assay for SARS-CoV-2 infection: Uses and limitations - p. 27 12. Chapter 4 Linking community participation, mobility disabilities, and the COVID-19 pandemic - p. 39 13. Chapter 5 Influence of the sources used to obtain information on COVID-19 and their impact on mental health - p. 49 14. Chapter 6 The psychological experiences and distress of defined populations in the COVID-19 pandemic: Doctors - p. 61 15. Chapter 7 Impact of COVID-19 on behavior in autism spectrum disorder - p. 79 16. Chapter 8 Prepandemic stressors in mental health responses to the COVID-19 pandemic: Early life adversities and beyond - p. 93 17. Chapter 9 Compulsive hoarding in the COVID-19 pandemic - p. 103 18. Chapter 10 The psychological experiences and distress in Japan and Sweden during the COVID-19 pandemic - p. 113 19. Chapter 11 The COVID-19 pandemic, mental health, and sleep: Linking depression, anxiety, and perceived stress - p. 125 20. Chapter 12 The COVID-19 pandemic and the occupational overload of health professionals: Indicators of burnout - p. 135 21. Chapter 13 Neurocognitive sequelae of SARS-CoV-2 infection: Pathogenesis, risk factors, assessment, and implications - p. 147 22. Chapter 14 Acute neurocognitive disorder as a presenting manifestation of COVID-19 - p. 161 23. Chapter 15 Mental health and the impact of confinement - p. 171 24. Chapter 16 Cannabis use in the COVID-19 pandemic: Changes in different populations and implications for policy - p. 183 25. Chapter 17 Impact of COVID-19 on women's mental health: Socioeconomic groups and global aspects - p. 197 26. Chapter 18 Quality of life assessment of patients after COVID-19 - p. 207 27. Chapter 19 COVID-19 pandemic and remote working: Toward a new way of working - p. 223 28. Chapter 20 Long COVID-19 and its persistence: A focus on mental health - p. 233 29. Chapter 21 The impact of the COVID-19 pandemic on behavioral and psychological features of vulnerable groups: Patients with multiple sclerosis and their quality of life - p. 245 30. Chapter 22 The COVID-19 pandemic and the interlink with psychological distress and eating behaviors - p. 253 31. Chapter 23 Linking pediatric COVID-19 with basal ganglia and dentate nucleus - p. 265 32. Chapter 24 Sensory disorders, neuroinflammation, and COVID-19 - p. 273 33. Chapter 25 The effects of COVID-19 isolations on nonmotor features of Parkinson’s disease - p. 285 34. Chapter 26 Myelitis following COVID-19 - p. 295 35. Chapter 27 The corpus callosum: Effects due to SARS-CoV-2 infection and the mRNA vaccine - p. 305 36. Chapter 28 Assessing the impact of prenatal SARS-CoV-2 exposure on infants’ neurodevelopment: A comprehensive analysis of current evidence - p. 317 37. Chapter 29 Electroencephalographic features with COVID-19 - p. 331 38. Chapter 30 Survivors of COVID-19 and clinical neuropsychological domain characteristics - p. 343 39. Chapter 31 Neuroinflammation following SARS-CoV-2 infection - p. 361 40. Chapter 32 Functional magnetic resonance imaging and depressive symptoms in subjects with COVID-19 - p. 373 41. Chapter 33 Impact of COVID-19 on the brain: Antibodies against brain stem antigens - p. 385 42. Chapter 34 The kynurenine pathway and role in mental health of post-COVID-19 patients - p. 393 43. Chapter 35 Management of brain tumors in the COVID-19 pandemic - p. 409 44. Chapter 36 The impact of the COVID-19 pandemic on ischemic stroke management: From hyperacute to chronic phase - p. 419 45. Chapter 37 Long COVID-19 and the potential use of palmitoylethanolamide - p. 429 46. Chapter 38 Cognitive assessments in post-COVID-19 syndrome: A focus on the neuropsychological tests and protocols - p. 441 47. Chapter 39 Supporting those with intellectual and developmental disabilities during the COVID-19 pandemic - p. 453 48. Chapter 40 Preserving well-being and quality of life through school-based interventions focused on physical activity during the COVID-19 pandemic - p. 463 49. Chapter 41 Hesitancy in using COVID-19 prevention behaviors among African Americans: Strategies to build confidence - p. 471 50. Chapter 42 New strategies for psychological well-being at work - p. 481 51. Chapter 43 Mitigating mental health changes with virtual reality technology during COVID-19 outbreak - p. 493 52. Chapter 44 Music therapy for patients with neurological disorders during COVID-19 pandemic - p. 501 53. Chapter 45 Mental health and the modulating effects of receiving the COVID-19 vaccination - p. 509 54. Chapter 46 Personalized cognitive behavioral therapy on patients with obesity in COVID-19 pandemic - p. 519 55. Chapter 47 Social anxiety disorder and COVID-19: Treatment with cognitive behavioral therapy - p. 533 56. Chapter 48 Burnout during the COVID-19 pandemic: Modulating role of mindfulness - p. 545 57. Chapter 49 Case study: Evaluation of a Long Covid Assessment Service (LCAS) - p. 557 58. Chapter 50 Case study: Navigating youth mental health and addictions care in the context of the COVID-19 pandemic - p. 565 59. Chapter 51 Case study: Restless leg syndrome associated with COVID-19 - p. 571 60. Chapter 52 Recommended resources linking neuroscience and behavior in coronavirus disease 2019 (COVID-19) - p. 579 61. Index - p. 593
Linking Neuroscience and Behavior in COVID-19 examines the impact of the virus and pandemic on behavior and mental health. Chapters look at those with pre-existing conditions, including dementia and multiple sclerosis, and how the pandemic has burdened them further. There is also discussion on the mental health consequences the pandemic has had and continues to have on the broad populace, including depression and anxiety, as well as neurological effects of the virus itself. Finally, managing care and treatment of conditions - those preceding, caused by, or emerging for the first time during the pandemic are also detailed.
1. Linking Neuroscience and Behavior in COVID-19 - p. iv 2. Cover - p. iv 3. Title Page - p. iv 4. Copyright Page - p. iv 5. Tables of Contents - p. iv 6. Dedication - p. iv 7. Contributors - p. xxi 8. Preface - p. xxvii 9. Chapter 1 The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic - p. 3 10. Chapter 2 Different variants of SARS-CoV-2 - p. 13 11. Chapter 3 Lateral flow assay for SARS-CoV-2 infection: Uses and limitations - p. 27 12. Chapter 4 Linking community participation, mobility disabilities, and the COVID-19 pandemic - p. 39 13. Chapter 5 Influence of the sources used to obtain information on COVID-19 and their impact on mental health - p. 49 14. Chapter 6 The psychological experiences and distress of defined populations in the COVID-19 pandemic: Doctors - p. 61 15. Chapter 7 Impact of COVID-19 on behavior in autism spectrum disorder - p. 79 16. Chapter 8 Prepandemic stressors in mental health responses to the COVID-19 pandemic: Early life adversities and beyond - p. 93 17. Chapter 9 Compulsive hoarding in the COVID-19 pandemic - p. 103 18. Chapter 10 The psychological experiences and distress in Japan and Sweden during the COVID-19 pandemic - p. 113 19. Chapter 11 The COVID-19 pandemic, mental health, and sleep: Linking depression, anxiety, and perceived stress - p. 125 20. Chapter 12 The COVID-19 pandemic and the occupational overload of health professionals: Indicators of burnout - p. 135 21. Chapter 13 Neurocognitive sequelae of SARS-CoV-2 infection: Pathogenesis, risk factors, assessment, and implications - p. 147 22. Chapter 14 Acute neurocognitive disorder as a presenting manifestation of COVID-19 - p. 161 23. Chapter 15 Mental health and the impact of confinement - p. 171 24. Chapter 16 Cannabis use in the COVID-19 pandemic: Changes in different populations and implications for policy - p. 183 25. Chapter 17 Impact of COVID-19 on women's mental health: Socioeconomic groups and global aspects - p. 197 26. Chapter 18 Quality of life assessment of patients after COVID-19 - p. 207 27. Chapter 19 COVID-19 pandemic and remote working: Toward a new way of working - p. 223 28. Chapter 20 Long COVID-19 and its persistence: A focus on mental health - p. 233 29. Chapter 21 The impact of the COVID-19 pandemic on behavioral and psychological features of vulnerable groups: Patients with multiple sclerosis and their quality of life - p. 245 30. Chapter 22 The COVID-19 pandemic and the interlink with psychological distress and eating behaviors - p. 253 31. Chapter 23 Linking pediatric COVID-19 with basal ganglia and dentate nucleus - p. 265 32. Chapter 24 Sensory disorders, neuroinflammation, and COVID-19 - p. 273 33. Chapter 25 The effects of COVID-19 isolations on nonmotor features of Parkinson’s disease - p. 285 34. Chapter 26 Myelitis following COVID-19 - p. 295 35. Chapter 27 The corpus callosum: Effects due to SARS-CoV-2 infection and the mRNA vaccine - p. 305 36. Chapter 28 Assessing the impact of prenatal SARS-CoV-2 exposure on infants’ neurodevelopment: A comprehensive analysis of current evidence - p. 317 37. Chapter 29 Electroencephalographic features with COVID-19 - p. 331 38. Chapter 30 Survivors of COVID-19 and clinical neuropsychological domain characteristics - p. 343 39. Chapter 31 Neuroinflammation following SARS-CoV-2 infection - p. 361 40. Chapter 32 Functional magnetic resonance imaging and depressive symptoms in subjects with COVID-19 - p. 373 41. Chapter 33 Impact of COVID-19 on the brain: Antibodies against brain stem antigens - p. 385 42. Chapter 34 The kynurenine pathway and role in mental health of post-COVID-19 patients - p. 393 43. Chapter 35 Management of brain tumors in the COVID-19 pandemic - p. 409 44. Chapter 36 The impact of the COVID-19 pandemic on ischemic stroke management: From hyperacute to chronic phase - p. 419 45. Chapter 37 Long COVID-19 and the potential use of palmitoylethanolamide - p. 429 46. Chapter 38 Cognitive assessments in post-COVID-19 syndrome: A focus on the neuropsychological tests and protocols - p. 441 47. Chapter 39 Supporting those with intellectual and developmental disabilities during the COVID-19 pandemic - p. 453 48. Chapter 40 Preserving well-being and quality of life through school-based interventions focused on physical activity during the COVID-19 pandemic - p. 463 49. Chapter 41 Hesitancy in using COVID-19 prevention behaviors among African Americans: Strategies to build confidence - p. 471 50. Chapter 42 New strategies for psychological well-being at work - p. 481 51. Chapter 43 Mitigating mental health changes with virtual reality technology during COVID-19 outbreak - p. 493 52. Chapter 44 Music therapy for patients with neurological disorders during COVID-19 pandemic - p. 501 53. Chapter 45 Mental health and the modulating effects of receiving the COVID-19 vaccination - p. 509 54. Chapter 46 Personalized cognitive behavioral therapy on patients with obesity in COVID-19 pandemic - p. 519 55. Chapter 47 Social anxiety disorder and COVID-19: Treatment with cognitive behavioral therapy - p. 533 56. Chapter 48 Burnout during the COVID-19 pandemic: Modulating role of mindfulness - p. 545 57. Chapter 49 Case study: Evaluation of a Long Covid Assessment Service (LCAS) - p. 557 58. Chapter 50 Case study: Navigating youth mental health and addictions care in the context of the COVID-19 pandemic - p. 565 59. Chapter 51 Case study: Restless leg syndrome associated with COVID-19 - p. 571 60. Chapter 52 Recommended resources linking neuroscience and behavior in coronavirus disease 2019 (COVID-19) - p. 579 61. Index - p. 593
